eClinical Trial Software
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
58
NCT06157541
T Cells and Pembrolizumab for Recurrent and Newly Diagnosed Glioblastoma
Phase: Phase 1/2
Role: Collaborator
Start: Feb 8, 2024
Completion: Jan 31, 2028
Loading map...